LCAR-BCDR Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LCAR-BCDR Cells, covering 2025-07-24 to 2025-07-24. Get the full timeline:
Most recent: Clinical Trial Update: BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]